Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,629 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 903
Recruiting: 504
Ph III recruiting: 46
Growth YoY: +21.9%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 401–404 of 404 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05679583	Preoperative Stereotactic Body Radiation Therapy in Patients With Resectable Pancreatic Cancer	recruiting	Phase 2	25	Yonsei UniversityOTHER	1	Jan 11, 2023	clinicaltrials
NCT04361162	Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer	active not recruiting	Phase 2	30	Massachusetts General HospitalOTHER	1	Sep 8, 2022	clinicaltrials